1. Home
  2. NSPR vs GCV Comparison

NSPR vs GCV Comparison

Compare NSPR & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • GCV
  • Stock Information
  • Founded
  • NSPR 2005
  • GCV 1988
  • Country
  • NSPR United States
  • GCV United States
  • Employees
  • NSPR N/A
  • GCV N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • GCV Finance/Investors Services
  • Sector
  • NSPR Health Care
  • GCV Finance
  • Exchange
  • NSPR Nasdaq
  • GCV Nasdaq
  • Market Cap
  • NSPR 79.7M
  • GCV 75.6M
  • IPO Year
  • NSPR N/A
  • GCV N/A
  • Fundamental
  • Price
  • NSPR $2.36
  • GCV $3.70
  • Analyst Decision
  • NSPR Strong Buy
  • GCV
  • Analyst Count
  • NSPR 2
  • GCV 0
  • Target Price
  • NSPR $4.50
  • GCV N/A
  • AVG Volume (30 Days)
  • NSPR 50.0K
  • GCV 57.9K
  • Earning Date
  • NSPR 05-09-2025
  • GCV 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • GCV 13.04%
  • EPS Growth
  • NSPR N/A
  • GCV N/A
  • EPS
  • NSPR N/A
  • GCV N/A
  • Revenue
  • NSPR $7,027,000.00
  • GCV N/A
  • Revenue This Year
  • NSPR $28.93
  • GCV N/A
  • Revenue Next Year
  • NSPR $172.18
  • GCV N/A
  • P/E Ratio
  • NSPR N/A
  • GCV N/A
  • Revenue Growth
  • NSPR 8.49
  • GCV N/A
  • 52 Week Low
  • NSPR $2.07
  • GCV $3.15
  • 52 Week High
  • NSPR $3.80
  • GCV $4.58
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 38.53
  • GCV 63.04
  • Support Level
  • NSPR $2.31
  • GCV $3.53
  • Resistance Level
  • NSPR $2.69
  • GCV $3.59
  • Average True Range (ATR)
  • NSPR 0.18
  • GCV 0.07
  • MACD
  • NSPR -0.02
  • GCV 0.03
  • Stochastic Oscillator
  • NSPR 10.42
  • GCV 83.33

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.

Share on Social Networks: